Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
C4 Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CCCC
Nasdaq
8731
https://c4therapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for C4 Therapeutics Inc
Here’s Why Meridian Small Cap Growth Fund Trimmed C4 Therapeutics (CCCC)
- Mar 28th, 2024 8:36 am
C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024
- Mar 5th, 2024 9:30 pm
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
- Mar 4th, 2024 12:00 pm
New Forecasts: Here's What Analysts Think The Future Holds For C4 Therapeutics, Inc. (NASDAQ:CCCC)
- Feb 27th, 2024 10:29 am
C4 Therapeutics Full Year 2023 Earnings: Misses Expectations
- Feb 24th, 2024 12:38 pm
C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Misses Revenue Estimates
- Feb 22nd, 2024 1:15 pm
C4 Therapeutics Inc (CCCC) Reports Full Year 2023 Financial Results and Business Updates
- Feb 22nd, 2024 12:36 pm
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
- Feb 22nd, 2024 12:00 pm
Earnings Preview: Alector (ALEC) Q4 Earnings Expected to Decline
- Feb 20th, 2024 3:00 pm
C4 Therapeutics (CCCC) to Report Q4 Earnings: What's in Store?
- Feb 15th, 2024 3:19 pm
C4 Therapeutics, Inc. (CCCC) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
- Feb 15th, 2024 3:00 pm
C4 (CCCC) Up 6% on Restructuring Plan to Curb Cash Burn
- Jan 11th, 2024 4:44 pm
C4 Therapeutics, Inc. (CCCC)'s Technical Outlook is Bright After Key Golden Cross
- Jan 9th, 2024 11:20 pm
C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
- Jan 9th, 2024 9:01 pm
Axsome (AXSM) Surges 7.8%: Is This an Indication of Further Gains?
- Jan 5th, 2024 1:30 pm
C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
- Jan 4th, 2024 9:01 pm
C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 4th, 2024 12:00 pm
C4 Therapeutics (CCCC) Gains 310% in 3 Months: Here's Why
- Jan 3rd, 2024 4:10 pm
Wall Street Analysts See a 197.7% Upside in C4 Therapeutics, Inc. (CCCC): Can the Stock Really Move This High?
- Jan 1st, 2024 2:55 pm
Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?
- Dec 29th, 2023 2:40 pm
Scroll